Günther R. Adolf

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo

Martin Steegmaier, Matthias Hoffmann, Anke Baum et al. · Current Biology · 2007 · 839 citations · Full text

Tumor Biology, Bi 2536, Medicine +9

HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin

Ricardo Pujol‐Borrell, Ian Todd, Mala Doshi et al. · Nature · 1987 · 446 citations

Inflammation, Histocompatibility, Human Islet Cells +15

BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity

Dorothea Rudolph, Martin Steegmaier, Matthias Hoffmann et al. · Clinical Cancer Research · 2009 · 388 citations · Full text

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.

Gerrit Koopman, Karl‐Heinz Heider, E Horst et al. · The Journal of Experimental Medicine · 1993 · 305 citations

Lymphoid Neoplasia, Exon V6, Aggressive Non-hodgkin +13

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis

Christoph Klade, Tilman Voss, E. Krystek et al. · PROTEOMICS · 2001 · 204 citations

Renal Pathology, Immunology, Pathology +16